Subsequent development of histiocytic sarcoma and follicular lymphoma: cytogenetics and next-generation sequencing analyses provide evidence for transdifferentiation of early common lymphoid precursor-a case report and review of literature

Virchows Arch. 2020 Apr;476(4):609-614. doi: 10.1007/s00428-019-02691-w. Epub 2019 Dec 5.

Abstract

Histiocytic sarcoma (HS) is a rare aggressive hematologic neoplasm that can be associated with low-grade B cell lymphoma. The development of both neoplasms is currently being considered a transdifferentiation mechanism but remains elusive. We report the case of a 65-year-old patient with synchronous development of peritoneal/abdominal HS and grade 1-2 follicular lymphoma (FL). Cytogenetic analysis and targeted next-generation sequencing of both FL and HS tumors identified common genomic alterations such as IGH-BCL2 rearrangement, CREBBP and KMT2D, and aberrations of chromosomes 9q and 19q. However, only the HS tumor had a KRAS mutation while the lymph node involved by FL harbored a TNFAIP3 mutation and both tumors also showed distinct chromosomal alterations. This report strengthens the hypothesis of a common lymphoid progenitor which accumulates genetic alterations leading to two different hematologic malignant diseases with significantly distinct prognoses.

Keywords: Follicular lymphoma; Histiocytic sarcoma; Targeted next-generation DNA sequencing; Transdifferentiation.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Aged
  • Cell Transdifferentiation / physiology*
  • DNA-Binding Proteins / genetics
  • Histiocytic Sarcoma / diagnosis
  • Histiocytic Sarcoma / pathology*
  • Humans
  • Lymph Nodes / pathology
  • Lymphoma, B-Cell / pathology*
  • Lymphoma, Follicular / pathology*
  • Male
  • Neoplasm Proteins / genetics
  • Prognosis

Substances

  • DNA-Binding Proteins
  • KMT2D protein, human
  • Neoplasm Proteins